Association between mid-term worsening renal function and mortality after transcatheter aortic valve replacement in patients with chronic kidney disease.
Derek Q PhanMing-Sum LeeVicken AharonianPrakash MansukhaniNaing MooreSomjot S BrarRay ZadeganPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
Among patients with baseline renal dysfunction, only 15% developed worsening renal function at 3-6 months after TAVR, which was associated with increased mortality. Predictors for worsening renal function include AKI and blood transfusions. Preventative measures peri-procedurally and continued monitoring post-discharge are warranted to improve outcomes.